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Although the rearrangement strategies of immunogiobulin genes afford great 
antibody diversity (1-6), the ontogenetic mechanisms that dictate which members 
of this potential array exist among antigen-responsive B cells are poorly under- 
stood. Several laboratories have reported a staged developmental appearance of 
clonotypes among inbred  individuals,  suggesting that  some steps  involved in 
establishing the primary B cell repertoire are under intrinsic genetic control (7- 
17).  In secondary situations, however, it is clear that prior contact with antigen 
can alter  the repertoire as a  result of selective clonal expansion,  deletion, or 
suppression (17-22). Most previous studies have focused exclusively upon either 
the  genetics  of clonotype appearance  (9-16,  23-26),  or  upon  the  effects of 
receptor-mediated changes in the repertoire (18-21).  However, it is likely that 
these  two parameters closely interact to  shape  the  ultimate phenotype of an 
individual. 
Useful information about these interactions has come from limiting dilution 
analysis of murine B cells responsive to the influenza A hemagglutinin molecule 
(HA).~  Recent studies with this system have shown that the clonal composition 
of the primary HA-reactive B cell pool  changes rapidly and regularly during 
early life (17), but that exposure to antigen perturbs this normal turnover by (a) 
preserving clones that are otherwise transiently expressed, and (b) preventing 
the appearance of certain other HA-specific clones. 
These findings suggested that the B cell repertoire can be selectively fixed by 
antigen exposure, the particular clonotypes selected reflecting the composition 
of the primary B cell pool at the time of exposure. We have tested this notion 
by characterizing the HA-responsive repertoires of adults that had been immu- 
nized  during  neonatal  life.  The  results  show  that  varying the  age  at  which 
immunization first occurs alters the adult clonal profiles obtained. Furthermore, 
the composition of the primary B cell pool at the time of initial antigen exposure 
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is predictive of the selected adult phenotype. The mechanisms responsible have 
also been investigated, and at least two events are instrumental in ligand-driven 
fixation  of phenotype.  First,  responsive  B  cell  clones  present  at  the  time  of 
challenge are expanded and driven to a serologically distinguishable differentia- 
tion  state  that  is  resistant  to  induced  T  cell-mediated  suppression.  Second, 
suppressor  T  cells  are  concomitantly generated  that  ablate  primary,  but  not 
secondary B cell responses in vivo. 
Materials and Methods 
Mice.  Adult DBA/2 and BALB/cByJ mice were obtained from the Jackson Labora- 
tory, Bar Harbor, ME. Neonatal BALB/c mice were produced in the breeding colony of 
M. P. Cancro. 
Viruses and Immunizations.  The following influenza A virus strains were used: PR8 (A/ 
PR/8/34  [HON1]);  WSE  (A/WSE/33  [HON1]);  MEL  (A/Mel./45  [HON1]);  BEL 
(A/Bel./42 [HON1]); Eq-PR8 (A/equine/Miami/I/63 [neq 2]-A/PR/8/34 [N1]; BH 
(A/BH/35  [HON1]);  WEISS (A/Weiss/43  [HON1];  CAM  (A/Cam./46  [HIN1]; the 
influenza  B  virus,  LEE;  and  E3376,  the  recombinant  virus  (A/PR/8/34-A/HK/ 
8/68 [HON2]) originally obtained from P. Palese and J. Schuiman, Mount Sinai School 
of Medicine, New York. All virus strains were initially provided by Dr. Walter Gerhard 
(Wistar  Institute,  Philadelphia,  PA).  Virus  growth,  purification,  and  quantitation  by 
hemagglutination titration were accomplished as described previously (23-29). Recipient 
DBA/2 mice received 1,000 hemagglutinating units (HAU) of PR8 intraperitoneally (i.p.) 
6 wk before use as recipients in splenic fragment cultures. Neonatal BALB/c mice were 
immunized i.p. at either 3 and 6 d  of age or at 2 wk of age, with  1,000 HAU of UV- 
inactivated PR8 virus. These mice and their unimmunized control littermates, as well as 
the mother, were tested for virus-specific serum antibodies by radioimmunoassay. Virus 
was inactivated by irradiation with a General Electric G8T5 UV lamp for 15 s at a distance 
of 10 cm. The virus sample was in a small volume and constantly stirred during irradiation 
to ensure uniform inactivation. 
Limiting Dilution Splenic Fragment Cultures.  Monoclonal antiviral antibodies were ob- 
tained in vitro from splenic fragment cultures (23-29). Single-cell suspensions of donor 
spleen cells were transferred intravenously (i.v.) to PR8-immunized DBA/2 mice that had 
received 1,500 rads (15 grays) of whole body irradiation. Spleen cells were prepared from 
each donor and transferred in aliquots of 5 ×  10~-2 ×  107 cells to individual recipients. 
Fragments were prepared from recipient spleens and  stimulated  with  PR8  in vitro as 
described previously (23-29). 
Radioimmunoassay (RIA)for Anti-influenza Antibody.  Culture fluids were assayed for the 
presence of antiviral  antibodies  by  solid-phase  RIA  (23-29).  Briefly, 20  #1  of either 
standard HA-specific hybridoma proteins, culture fluids, or serum dilutions, were added 
to wells of polyvinyl microtiter V-plates (Dynatech Laboratories, Arlington, VA), to which 
20  HAU of purified virus had previously been adsorbed.  Plates were developed with 
affinity-purified, radioiodinated goat antibody to mouse ~, ~, or a  chains, or with rabbit 
antibody to mouse Fab. 
Specificity and Reactivity Pattern Analysis of Monodonal  Antibodies.  Monoclonal antiviral 
antibodies generated in limiting dilution culture were tested for HA specificity by RIA 
against three viruses: PR8, the stimulating virus; E3376, a recombinant virus that shares 
the hemagglutinin with PR8 and has the neuraminidase of (A/HK/8/68 [H3N2]); and 
B/LEE,  an  influenza  B  virus  that  shares  with  PR8  only chicken  host  component, a 
carbohydrate moiety acquired during viral growth in eggs. Only antiviral antibodies that 
reacted with PR8 and E3376 but failed to react with B/LEE were considerd HA-specific. 
Reactivity pattern (RP) analysis was performed on all HA-specific culture fluids by RIA 
using  isotype-specific reagents.  Each  fluid  was  assessed  for  binding  to  PR8  and  six 
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Hybridoma Antibodies.  Several hybridoma antibodies were used in conjunction with a 
mixture of rabbit and guinea pig complement (C') in the preparation of cells for in vitro 
culture or in vivo adoptive transfer experiments. 
The rat anti-mouse IgMk hybridoma, Jlld (30), was kindly provided by Dr. J.  Sprent 
(Univ. of Pennsylvania School of Medicine, Philadelphia, PA). This antibody detects a cell 
surface antigen present on most mature B cells. The Jlld antibody was either used alone 
as  a  means  of delineating primary  from  secondary  splenic  B  cells,  or  was  used  in 
conjunction with an anti I-A  d monoclone for the removal of B cells from lymph node cell 
preparations. 
The  anti-l-A  d hybridoma,  MKD6,  originally  described  by  Kappler  et  al.  (31),  was 
obtained from the American Type Culture Col|ection, Rockville, MD. 
The anti-Thy-I monoclone, J1J, was also provided by Dr. J. Sprent (30), and was used 
to deplete T  cells from spleen cell preparation. 
The anti-Lyt-2.2  hybridoma antibody (32)  3.168.8,  was used to deplete some lymph 
node T  cell preparations of suppressor activity. 
Preparation of Lymph Node  T  Cells.  The  cervical,  axillary,  inguinal,  and  mesenteric 
lymph nodes were removed from chronically immunized or normal BALB/c mice, placed 
in medium, and homogenized in a  15-ml ground glass tissue homogenizer. After passage 
through nylon mesh, the cell suspension was washed twice by centrifugation at 1,500 rpm 
for  10  min at  4°C.  The  final  cell  pellet  was resuspended  in  1 ml  of medium  and  cell 
number and viability determined. Cells were then treated with a mixture of the monoclonal 
antibodies Jlld and MKD6. The lymph node cells were adjusted to 4  ×  107 cells/ml in a 
final  volume that  was  1/5 Jlld  (hybridoma supernatant)  and  1/20  MDK6  (hybridoma 
ascites).  After incubation  for 45  min at  4°C, complement and DNAse (1  mg/ml) were 
added at  1/12 and  1/25 final volume, respectively. The resulting mixture was incubated 
for 40 rain at  37°C. Subsequently an aliquot was taken  to assess the cytotoxicity of the 
antibody-complement mixture and the suspension was diluted  1 : 1 cold medium. Aliquots 
of 3 ml were placed in siliconized  15-ml tubes (vacutainer, Becton-Dickinson), underlay- 
ered with 4 ml of Ficoll-Isopaque, and spun at 20°C at 3,000 rpm for 15 min. Cells were 
collected from the interface, diluted with cold medium, and washed twice at 4°C. Viability 
was >95%, and treatment with monoclonal anti-Thy-1 antibody routinely gave cytotoxicity 
indices of >95%. Cells were resuspended, counted, and diluted with DME for intravenous 
injection in 0.2-ml aliquots. 
Preparation ofLyt-2-Depleted T Cells.  Some lymph node T cell preparations were treated 
with  monoclonal  anti-Lyt-2.2  antibody  plus  complement  for  45  min  at  37°C.  After 
treatment,  cells were diluted with medium and spun over Ficoll-Isopaque, as above. The 
efficiency of Lyt-2  + T  cell depletion  was assessed  by treating the cell  preparation  with 
anti-Lyt-2 in a  cytotoxicity assay.  Residual  Lyt-2  + cells routinely accounted for <2% of 
the T  cell preparation. 
Treatment of Spleen Cells withJlld.  Spleen cell suspensions were prepared by perfusion 
of spleens and passage of the cells through nylon mesh. Cells were centrifuged at  1,500 
rpm for 10 min at 4°C and then treated with ammonium chloride-Tris, 4 ml per spleen, 
at  37°C for 5  min.  Volume was doubled  with  cold medium and the cells were washed 
twice at  1,500 rpm for  10 min at 4°C.  Cells were suspended  at  4  ×  107 cells/ml  in a 
mixture containing 0.5  ml J]ld per  1 ×  108 cells,  complement, and  40 tsg/ml  DNAse. 
Cells were incubated for 45 rain at 37°C. An aliquot was taken to assess cytotoxicity, and 
the remaining diluted with an equal volume of medium, spun over Ficoll-Isopaque, and 
washed twice. 
Hemagglutination Inhibition.  HA-specific serum antibody was quantified by hemagglu- 
tination inhibition (HI). Serum (0.1  ml) was mixed with 0.1  ml of HAS and 0.1  ml of a 
1/100 dilution  of trypsin stock solution.  The resulting mixture  was incubated at  50°C 
for 30 min, then cooled to 26°C. Subsequently,  1.0 ml of 0.01  M NaIO4 was added and 
the mixture allowed to stand for 30 rain at 26°C. After this,  0.2 ml of glycerol in saline 
(60 g/l) was added. After 10 min, 0.5 ml of HAS was added to yield a  1:20 final dilution 
of the original serum. 
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dilution was mixed with 25 gl of HAS containing 4 HAU of either PR8 or CAM. Assays 
were carried out in 96-well round bottom plates (Linbro). After 1 h at 20 °, 50 #1 of a  1% 
suspension of washed chick erythrocytes in HAS was added. 
After gentle agitation, the plates were allowed to stand for 40 min, and the number of 
inhibited wells were scored. Quantitation was accomplished with monoclonal HA-specific 
antibodies derived from hybridomas. 
Results 
In previous studies, (17, summarized in Fig. 1, panels A, B, and C), we showed 
that the PR8 HA-responsive primary repertoire changes considerably between 1 
and 2 wk of age (panels A and B). Interestingly, this change is less marked if PR8 
is administered at 1 wk of age and the immunized mice examined at 2 wk of age 
(panel C). Exposure to the antigen thus tends to "fix" the repertoire by preserving 
some existing specificities and deleting or concealing others. In addition, several 
clonotypes that had not been observed among normal neonates were repeatedly 
found among the immunized individuals (right side of Fig. 1, panel C). 
Reactivity  Patterns of Adult Mice Given  PR8 as Neonates.  In order to establish 
whether this  was a  transient or  long-lived effect, BALB/c  mice were initially 
immunized at both  3 and 6  d  of age with  1,000  HAU of UV-inactivated PR8 
virus, and then were either treated weekly with the same antigen dose (chronic 
regimen),  or  were  untreated  (acute  regimen).  Other  mice  received antigen 
chronically but beginning at 2  wk of age. At 7-8  wk of age, these mice were 
used as B cell donors for limiting dilution splenic fragment cultures.  Previous 
studies (17) showed that such immunizations elicit virus-specific serum antibody, 
and that the procedures employed do not cross-immunize the nursing mothers. 
Chronic exposure to PR8 increases the frequency of HA-responsive B cells 25- 
fold over that  of unimmunized adults,  and acute exposure results in  a  6-fold 
increase in frequency (Table I). 
The results of RP analysis are shown in Fig.  1, where the clonal composition 
of immunized animals is compared to that of normal individuals.  The striking 
finding  is  that  the  RP  seen  among adult  mice either  chronically or  acutely 
challenged with PR8 from 1 wk of age (Fig.  1, panels D and E) are very similar 
to the RP observed in 2-wk old mice primed at 1 wk (panel C). In each of these 
situations, the RP are more similar to those observed in normal 1-wk old mice 
than those seen in either unprimed 2-wk old mice (panel B) or adult mice (panel 
G). For example, after chronic immunization (panel D), six of the eight RP persist 
that are both characteristic of the 1-wk repertoire and only transiently expressed 
in unimmunized mice, while few RP characteristic of the normal 2-wk repertoire 
(panel B) are observed. Also, the repertoires of adults immunized at 1 wk of age 
contain the same novel clonotypes (RP) seen in our previous study of 2-wk old 
immunized animals (right side of panels C, D, and E). Likewise, the RP observed 
among adults given PR8 beginning at 2 wk of age (panel F) closely resembles the 
pattern characteristic of normal 2-wk old mice. 
Statistical evaluation (34) upholds both the conclusion that immunized individ- 
uals  display  repertoires  most  similar  to  that  characteristic  of the  age  when 
immunization first occurred; as well as the conclusion that the repertoire is less 
diverse among neonatally immunized adults than among unimmunized adults. 
This is clear from inspection of Fig.  1, panel G, where (a) a  similar size sample 1 16  NEONATAL  IMMUNIZATION  INDUCES  RESTRICTED  ADULT  REPERTOIRES 
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REACTIVITY PATTERN 
FIGURE  l.  Reactivity  pattern  (RP)  analysis  of  HA-specific  antibodies  from  normal  and 
neonatally immunized BALB/c  mice. The HA-specific monoclonal antibodies derived from 
splenic  fragment  cultures  were  assayed  for  binding on  six  heterologous  viruses  by  RIA. 
Because they are monoclonal, each antibody recognizes a single determinant on the immuniz- 
ing HA molecule. Depending on  the distribution of the recognized  determinant among the 
heterologous viral HA, a characteristic array of positiveand negative reactions is obtained for 
each  antibody.  Each  potential  RP  defines  a  clonotype  or  small  set  of  clonotypes  that  is 
necessarily distinct from clonotypes yielding any other RP. Each vertical bar shows the relative 
frequency of a given RP, and each horizontal line within a bar represents a single antibody. 
Each panel shows the results obtained from animals of a particular treatment (TRT) group. 
Panels A and B show the HA-responsive  repertoires  of unimmunized BALB/c  mice at  3-6 
and  19-14  d  of age,  respectively.  Panel C shows the  HA-responsive  repertoire  of 2-wk old 
mice immunized at 3 and 6  d of age.  Panels D and E show the repertoires of adult mice that 
had been either chronically or acutely immunized beginning at 3-6 d  of age.  Panel F shows 
the repertoire  of adult mice that had been chronically immunized beginning at  19-14  d  of 
age. The repertoire observed among a sample of unimmunized adults is shown in panel G. THOMPSON  ET  AL.  1 17 
TAnLE  I 
Frequency of HA-Spec~c B Cells Among Normal and Immunized BALB / c Mice* 
Age  Age at initial PR8 im-  Immunization  ° regi-  HA-Specific  ! cells per 
munizations*  men  106 splenic B cells 
6d  --  --  8 
12-14 d  --  --  3 
13-14 d  Day 3-6  Acute  19 
Adult  --  --  13 
Adult  Day 3-6  Chronic  321 
Adult  Day 3-6  Acute  76 
Adult  Day 12-15  Chronic  312 
* The frequency of HA-responsive  splenic B cells was determined by limiting dilution splenic  fragment 
culture (23-28) as described in Materials and Methods. 
Mice were either unimmunized, or initially immunized with 1,000 HAU of UV-inactivated PR8 at 
the age shown. 
Among immunized mice; either chronic or acute dose regimens were employed. Acutely immunized 
mice were given the initial dose of PR8 only. Chronically immunized mice received 1,000 HAU of 
UV-inactivated PR8 weekly following initial immunization; and received their final dose of virus 7 
d before use as spleen cell donors in limiting dilution culture. 
! The values given are after correction for the proportion of B cells in the inoculum (17), as well as 
homing and cloning efficiency (33). 
from normal  adults  yields  twice  the  number  of different  RP  than  within  any 
group of neonates; and (b) a  large proportion of the adult RP have never been 
observed among neonates (far right column of panel G). 
These data imply that neonatal antigen exposure creates an oligoclonal adult 
repertoire, characterized by the presevation and dominance of clonotypes avail- 
able at the time of initial exposure. 
The persistence of particular clonotypes for prolonged periods after antigen 
priming is consistent  with  the  well established  view that  most memory B  cells 
have a  long life span.  However, it is less easy to explain  the fact that priming 
restricts the size (heterogeneity) of the repertoire. Since the precursor frequencies 
of immunized mice are  far higher than  in  unimmunized individuals  (Table I), 
one could argue that the restricted repertoire of neonatally primed mice may be 
only quantitative,  and  reflect inadequate  sample  size.  According  to  this  idea, 
analysis of very large numbers of HA-specific B cells from immunized mice might 
eventually reveal  all  reactivity patterns  found  in  normal  adults.  Alternatively, 
antigen  priming  might  induce  suppression,  which  prevents  the  emergence  or 
stimulation of new anti-HA specificities. This explanation, however, forces one 
to  argue  that  primed  and  unprimed  B  cells  are  qualitatively  different,  only 
unprimed B cells being susceptible to suppression. 
To examine this possibility, we compared primed and unprimed HA-specific 
B cells for (a) the presence of the Jlld antigen, a putative marker for memory B 
cells, and (b) susceptibility to T  cell-mediated suppression. 
Expression  of  Jlld Antigen Among Primed vs. Unprimed HA-Spec~c B Cells.  Bruce 
et al. (30) have reported that the rat anti-mouse monoclonal antibody, Jlld, lyses 
>90% of splenic B cells in the presence of complement; and greatly reduces the 
primary immune responses to antigens such as fowl gamma globulin. In marked 
contrast, secondary responses to these antigens are not detectably altered. 
In the present experiments, the frequency of HA-specific B cells in the Jlid- 1 18  NEONATAL  IMMUNIZATION  INDUCES RESTRICTED  ADULT  REPERTOIRES 
population of both normal and chronically immunized adults was determined by 
limiting dilution splenic fragment culture. 
As shown in Table II, the few remaining splenic B cells that survive treatment 
with Jlld  and  complement  have a  similar  frequency of HA-responsive  cells as 
unseparated splenic B  cells.  Since this treatment  lyses >90%  of the  Ig  + cells, it 
follows  that  the  vast  majority  of unprimed  HA-specific  B  cells  are Jlld +.  In 
contrast, treatment of primed B cells with Jlld and complement causes a marked 
(12-fold) enrichment in the frequency of HA-specific B cells. Thus HA-reactive 
cells from primed mice are predominantlyJlid-. These data confirm that primary 
and secondary HA-reactive cells show qualitative differences and provide a means 
to assess functional changes associated with priming. 
Suppressor T  Cells that Differentially Affect Primar~ vs. Secondary B  Cell Responses 
ctre Induced  by Neonatal Antigen  Challenge.  T  cells  from either chronically im- 
munized  or  normal  BALB/c  mice  were  transferred  to both  PR8-primed  and 
normal BALB/c recipients. The recipients were immunized with PR8 2 d  after 
T  cell transfer, and bled 6, 8, and  10 d after immunization. The sera was tested 
for HA-specific antibody titer by hemagglutination inhibition. 
T  cells derived from chronically exposed mice routinely suppressed primary 
HA-specific antibody responses,  whereas  T  cells  from unimmunized  mice  had 
no effect (Table III).  The suppressive effects were abolished by treating the T 
cell inoculum with anti-Lyt-2 and C', as well as by irradiation of transferred cells 
with  1,500 rads.  In contrast, secondary humoral responses were not susceptible 
to suppression even at doses of 107 transferred cells; which is 10-fold higher than 
the dose necessary to ablate primary responses. Finally, doses of 107 T  cells had 
no  effect upon  primary  DNP-specific  responses  induced  by  DNP-hemocyanin 
(data not shown). Neonatal immunization thus induces Lyt-2  ÷, radiation-sensitive, 
suppressors that act upon primary but not secondary B cell responses to the same 
antigen. 
Studies with an adoptive transfer system showed that T  cells from chronically 
PR8 primed mice failed to support responses by purified unprimed B cells. The 
TABLE  lI 
Antigen Priming Changes the Distribution of HA-reactive B Cells 
Among Subsets D~ned by the Jlld Marker* 
HA-Specific foci* per  HA-Specific  foci per 106 
B cell donor sta-  106 injected B lympho-  injectedJIId- B lympho- 
tus  cytes  cytes 
Normal  0.52 (0.35-0.62)  1.3 (0.6-2.2) 
PR8 immune  12.70 (i2.4-12.8)  161 (107-200) 
* SplenicJlld- B cells were prepared as described in Materials  and Methods 
from either normal BALB/c adults, or age-matched animals that had 
been immunized with 1,000 HAu of PR8 at 3 and 6 d of age and weekly 
thereafter. Splenic  J]ld- cells were pooled from several individuals, and 
either 2 × 107 cells from normal mice, or 1 x 105 from immunized mice 
were adoptively transferred  to recipients for limiting dilution splenic 
fragment culture. Total B cell inoculums were prepared  by treatment 
with anti-Thy-1 only. 
Value5 given are the arithmetic means of at least four experiments. The 
range of values between experiments are shown in parentheses. THOMPSON  ET  AL. 
TAnLE  III 
Neonatal Antigen Challenge Induces Suppressors Capable of Ablating Primary, but Not 
Secondary HA-Spec~c Humoral Responses In Vivo 
119 
Donor L.N.* T  cells  T  cell donor* treat-  Recipient~  HA-Specific[[ antibody 
transferred  ment 
#g/ml 
--  --  Normal  65; 130; 190 
--  --  PR8 primed  350; 250; 360; 175 
1 ×  107  Chronic PR8  Normal  <10; <10; <10; 30 
1 x  106  Chronic PR8  Normal  <10; 50; <10; 30 
5 ×  10  ~  Chronic PR8  Normal  75; 175; 80; 80 
1 x  107  Chronic PR8  PR8 primed  350; 375 
1 x  106  Chronic PR8  PR8 primed  350; 750; 750; 750 
1 x  107  None  Normal  90; 180; 165; 90; 260 
1 ×  107  None  PR8 primed  350; 700; 750; 750 
1  x  107  after  anti-Lyt-2  Chronic PR8  Normal  150; 175 
and C' 
1 x  107 T  after irradiation  Chronic PR8  Normal  180; 260 
* All lymph node cells were treated with anti-I-A  ~ (MKD6) andJlld plus complement to yield a 97% 
Thy-1 ÷ cell population. In the last two treatment groups, these cells were also either treated with a 
monoclonal anti-Lyt-2 reagent (3.168.8) and C', which kills 22% of L.N.T-cells; or were irradiated 
(1,500 rads). 
* BALB/c donor mice were either untreated, or had received UV-inactivated PR8 chronically (1,000 
HAU/wk) beginning 3-6 d after birth. 
§ Recipients were either normal BALB/c mice or age-matched, PR8 immunized BALB/c mice. All 
recipients received 1,000 HAU of PR8 i.p. 2 d after T  cell transfer, and were bled at days 6, 8, 10 
after immunization. 
!  HA-specific antibody was determined by hemagglutination inhibition. This allows the detection of 
HA-specific antibody, but not antibodies directed to other viral antigens. Each number represents 
mean of triplicate determinations on an individual animal. 
same T  cells, however, provided excellent help for primed B cells, including the 
purified J 11 d- subset. Table IV shows the results obtained from such an exper- 
iment. Neither whole splenic B cells nor J1 ld- B cells from unimmunized mice 
respond to PR8 in the absence of cotransferred T  cells. Both such pools from 
immunized mice give rise to some PR8-specific serum antibody after challenge; 
suggesting that secondary, J1 ld-, B cells may have less stringent requirements 
for T  help than do primary cells. The key elements of the experiment, however, 
are the groups that show that J1 ld- B cells from chronically immunized mice 
respond even in the presence of T  cells that abolish the response of splenic B 
cells from nonimmune individuals. 
The data in Tables III and IV thus imply that: (a) PR8 primed T  cells comprise 
a mixture of suppressor and helper cells; (b) unprimed B cells are very sensitive 
to the suppressors; and (c) primed, J1 ld- B cells are resistant to suppression but 
remain responsive to help. 
PR8-Induced  Suppressors  Ablate B  Cell Responses  Directed  Towards Heterologous 
Viral HA. To establish whether the suppressors induced by neonatal challenge at 
3-6 d of age exhibit specificity via epitopes recognized by responding B cells; or 
instead exhibit broadly specific effects; the following experiment was performed. 
T  cells from mice chronically immunized with PR8 were tested for their ability 
to ablate primary responses to the heterologous influenza virus, CAM. This virus 120  NEONATAL  IMMUNIZATION  INDUCES  RESTRICTED  ADULT  REPERTOIRES 
TABLE  1V 
HA-Reactive, J1 I d- B Cells  from Immunized Mice are Resistant to Antigen-induced Suppression * 
Spleen cell donor  Spleen cell treat-  Lymph node T  cell  Recipient serum HA-specific 
treatment  ment  donor treatment  antibody after PR8 challenge  * 
ug / ml 
--  --  Normal  <10 <10 
--  --  Chronic PR8  <10 <10 
Normal  Thy-1  --  <10 <10 
Chronic PR8  Thy-1  --  130; 65 
Normal  Thy- 1  Normal  130; 130 
Normal  Thy- 1  Chronic PR8  <10; <10; <10 
Chronic PR8  Thy-1  Normal  735; 735; 735 
Chronic PR8  Thy-I  Chronic PR8  520; 735; 735 
Chronic PR8  Thy-1/J1 ld  Normal  520; 1040; 735; 735 
Chronic PR8  Thy-1/Jl ld  Chronic PR8  370; 735; 1040; 370; 735 
Normal  Thy-1/J1 ld  Normal  30; <10;  15; 30; 
Normal  Thy-l/J1 ld  Chronic PR8  <10; <10; 30; 15; <10 
* Spleen and lymph node cells were prepared from either normal BALB/c mice; or BALB/c mice 
that had been immunized chronically with PR8 beginning at 3 to 6 d of age. All donors were 7-8 
wk of age. Spleens and nodes were taken from the same animals. Lymph node T  cells were prepared 
by treatment with monoclonal anti-l-A and J1 ld as described in Materials and Methods. Spleen 
cells were treated with either anti-Thy-1 only, or with both with anti-Thy-I and J1 ld. These cells 
were transferred intravenously to irradiated (950 r) BALB/c mice. In all cases, doses of 2.5 x  107 
B cells and 1 x  107 T  cells were used. 
~; 2 d  after transfer, recipients were immunized with 1,000 HAU of UV-inactivated PR8 intraperi- 
toneally. Serum was collected on days 6, 8, and I0 after immunization, and assayed for PRS-specific 
antibody by both RIA and hemagglutination inhibition. The figures given are based on the day-6 
sera. 
was chosen because it shares very few epitopes recognized by the 3-6-d  PR8- 
responsive B cell repertoire. This is evident from Fig.  1, where few of the PR8- 
specific antibodies from normal 6-d old mice react with CAM. 
The results (Table V) indicate that PR8-induced suppressors are effective in 
preventing primary responses to CAM, as well. 
Discussion 
This work demonstrates a strong relationship between the normal turnover of 
primary B cell repertoire composition and the effects of antigen-driven events. 
Precedence for receptor-mediated repertoire  changes exists  in several experi- 
mental systems that involve neonatal exposure to either antigen or antiidiotypic 
antibodies. These treatments have led either to the loss of dominant clonotypes, 
or to  the enhanced representation  of minor clonotypes (18-22,  35-37).  The 
present study extends these findings in several ways: First, the behavior of the 
entire HA-responsive repertoire has been monitored, providing a more complete 
understanding of the processes exemplified by individual clonotypes in previous 
studies.  Second,  in  conjunction  with  our  previous  work,  which  defined  the 
dynamics of the neonatal HA-specific repertoire (17), the present findings help 
explain  the time-dependent nature  of these effects.  Third,  these experiments 
show that induction of characteristic clonal profiles involves changes in not only 
the frequency but the functional properties of stimulated B cell clones. Finally, 
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TABLE  V 
Suppressors Generated by PR8 Immunization Ablate Primary B Cell Responses to Heterologous 
Influenza A Virus Strains 
Donor L.N. T  Immunizing 
cells trans-  Donor treatment  t 
ferred*  antigen° 
HA-Specific antibody reactive with: 
PR8  CAM 
#g/ml 
--  --  PR8  130; 200; 160; 160  <10; 30; <10; <10 
--  --  CAM  40; 20; <I0; <10  200; 110; 80; 160 
1 x  107  Chronic PR8  PR8  20; <10; 20; <10  <10; <10; <10; <10 
1 x  106  Chronic PR8  PR8  20; 20; 40; 20  <10; <10; <10; <10 
1 X 107  Chronic PR8  CAM  <10; <10; <10; <10  <10; <10; <10; <20 
1 X I06  Chronic PR8  CAM  <10; <10; <10; <10  <I0; <10; <10; <10 
1 X 107  None  PR8  100; 80; 40; 160  40; <10; <10; 20 
1 x  107  None  CAM  40; 20; <10; <10  200; 110; 80; 160 
* Lymph node cells were prepared as in Table III. 
* Donor mice were treated as those in Table III. 
Recipients were normal (unimmunized) BALB/c mice at 6-8 wk of age. Each recipient received 
1,000 HAU of either PR8 or CAM 2 d  after T  cell transfer. Sera was taken at days 6, 8, and 10 
after immunization. 
!  HA-specific antibody was determined by hemagglutination inhibition. For each individual recipient, 
titration was performed for both PR8- and CAM-reactive antibody, by using the appropriate virus 
in the H1 assay. 
clonal profile. 
The resistance of primed B cells to T  cell-mediated suppression clearly confers 
a selective advantage in subsequent responses, since primary cells arising in the 
intervening  period  will  presumably  be  susceptible  to  suppression.  Although 
relative resistance of secondary B cells to T  cell-mediated suppression has been 
described in several other systems (38, 39), the present experiments indicate that 
the clonotypes within the suppression-resistant population can depend strongly 
upon the time of initial antigenic exposure. 
The  distribution  of HA-reactive  cells among J1 ld  + and J1 ld-  B  cells also 
changes markedly following immunization. Immunization may either preferen- 
tially expand pre-existing J 1 ld- B cells, or may instead induce the differentiation 
ofJ 11 d + B cells, which results in loss of the marker. Although we presently favor 
the latter possibility because of our inability to reconstitute HA-specific responses 
with J 11 d- cells from unprimed donors (Table IV), additional experiments will 
be required to assess these possibilities. 
Interpretive caution must be exercised regarding the J1 ld marker's apparent 
association  with  suppression  susceptibility.  For  example,  the Jlld ÷  to Jlld- 
transition may occur only after certain types of priming (e.g., thymus dependent 
vs. thymus independent), whereas functional changes may occur in all cases. 
Lengthened cellular half-life may also accompany stimulation and clonal ex- 
pansion. Several studies have suggested a rapid turnover for primary B cells (40, 
41), but more protracted decay rates for secondary B cells (42).  Because PR8- 
primed cells are serologically distinguishable from their unprimed counterparts 
by  the J1 ld  marker,  the possibility of induced changes in  half-life properties 
should be amenable to definitive analysis. 
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adults may also involve several mechanisms. First, B cell clones that arise in the 
presence of antigen  might be tolerized (43-45).  The similar skewing of adult 
phenotype after  acute as  well as  chronic doses of antigen,  however,  makes it 
unlikely that this is the sole mechanism responsible. The results suggest instead 
that active mechanisms play a  role, since suppressor populations are produced 
by neonatal immunization. The in vivo T  cell transfer experiments that demon- 
strate complete suppression of the primary HA-specific responses to both CAM 
and PR8 suggest that suppression is at least in part specific for conserved regions 
of the virus that are not necessarily those recognized by the B cells. This provides 
a plausible explanation for our inability to detect the broad array of clonotypes 
known  to  emerge  at  later  ages.  The  properties  of these  suppressors  closely 
parallel those of Ts populations described by Herzenberg et al. (46). The antigen- 
specific nature of suppression raises several issues. First, although primary clones 
that subsequently emerge will not participate in HA-specific responses, they may 
remain available for primary responses to other antigens. Second, antigen chal- 
lenge that  routes particular  B  cell clonotypes to a  suppression resistant  state, 
while at the same time inducing suppressors, could lead to apparent clonotype- 
specific suppression;  but  actually  reflect  the  distribution  of clonotypes within 
suppression-resistant vs. suppression-sensitive subsets. 
A particularly strong association can be made between the present observations 
and those of Fazekas de St. Groth and Webster (47), who showed that children 
previously immunized to one strain of influenza tended, upon secondary chal- 
lenge with a  heterologous strain,  to produce antibodies of greatest avidity for 
the HA of the virus used in the primary challenge. The findings presented herein 
closely parallel this observation, and they may provide a  mechanism to account 
for  this phenomenon, termed  "original  antigenic  sin."  Although  the  classical 
explanation also invokes stimulation of previously expanded, cross-reactive B cell 
clones  (48),  our  results  indicate  that  active  suppression  may also  be  a  major 
contributing factor. 
Summary 
The effects of neonatal antigen exposure on the adult B cell repertoire have 
been  examined  by  characterizing  the  influenza  hemagglutinin  (HA)-specific 
response of adult BALB/c mice given antigen soon after birth. Ligand exposure 
during early life exerts a profound and lasting effect upon the B cell repertoire, 
characterized  by the expansion and preservation of particular antigen-reactive 
clones and the apparent loss of others. The precise subset of clonotypes selectively 
preserved depends upon the age at  which antigen is first encountered; and is 
predictable  given a  knowledge of the  emerging primary  pool's dynamics and 
composition. 
The preserved (secondary) B cells differ from their unprimed precursors with 
respect  to  (a)  expression  of the  surface  marker  detected  by  the  monoclonal 
antibody J 11 d, and (b) susceptibility to T  cell-mediated suppression. 
These studies thus demonstrate a  strong relationship between the heritable 
dynamics of the emerging primary  B  cell  repertoire  and the effect of ligand- 
driven events upon repertoire phenotype. In addition, they provide a mechanistic 
model for  certain  forms of antigen-induced oligoclonal dominance,  especially THOMPSON  ET  AL.  123 
the phenomenon of original antigenic sin. 
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